Get the Stockscreener App
15.67
1.82%
0.28
Avantor Inc stock is traded at $15.67, with a volume of 4.24M.
It is up +1.82% in the last 24 hours and up +5.31% over the past month.
Avantor Inc provides products and services to customers in the biopharma, healthcare, education & government, and advanced technologies & applied materials industries. The company operates through two segments: Laboratory Solutions and Bioscience Production. It offers materials & consumables, equipment & instrumentation, and services & specialty procurement. Product groups include Equipment & Instrumentation, Services & Specialty Procurement, Proprietary Materials & Consumables, and Third-Party Materials & Consumables. Materials & consumables include high-purity chemicals and reagents, lab supplies, customized excipients, single-use assemblies, chromatography products, sample preparation kits, and fluid handling solutions. It operates in the Americas, Europe, and AMEA.
See More
Previous Close:
$15.39
Open:
$15.45
24h Volume:
4.24M
Relative Volume:
0.52
Market Cap:
$10.60B
Revenue:
$6.55B
Net Income/Loss:
$-551.40M
P/E Ratio:
-19.39
EPS:
-0.8082
Net Cash Flow:
$438.90M
1W Performance:
+2.15%
1M Performance:
+5.31%
6M Performance:
+97.85%
1Y Performance:
+15.73%
1-Day Range:
$15.41
$15.76
1-Week Range:
$14.96
$16.38
52-Week Range:
$7.265
$16.38
Avantor Inc Stock (AVTR) Company Profile
Name
Avantor Inc
Sector
Industry
Phone
(610) 386-1700
Address
RADNOR CORPORATE CENTER, BUILDING ONE, RADNOR, PA
Compare AVTR vs ISRG, BDX, RMD, MDLN, ALC
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
AVTR
Avantor Inc
|
15.67 | 10.60B | 6.55B | -551.40M | 438.90M | -0.8082 |
ISRG
Intuitive Surgical Inc
|
423.96 | 149.78B | 11.03B | 3.16B | 3.22B | 8.7251 |
BDX
Becton Dickinson Co
|
183.75 | 50.05B | 21.37B | 1.41B | 3.07B | 3.9437 |
RMD
Resmed Inc
|
230.05 | 32.35B | 5.54B | 1.52B | 1.74B | 10.37 |
MDLN
Medline Inc
|
36.26 | 31.81B | 29.14B | 1.07B | 1.05B | 1.1956 |
ALC
Alcon Inc
|
64.11 | 30.99B | 10.63B | 819.00M | 1.59B | 1.6577 |
Avantor Inc Stock (AVTR) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Sep-09-26 | Initiated | UBS | Neutral |
| Jul-29-26 | Upgrade | Jefferies | Underperform → Hold |
| Jun-26-26 | Resumed | Bernstein | Mkt Perform |
| Jun-02-26 | Resumed | Wolfe Research | Underperform |
| May-15-26 | Resumed | RBC Capital Mkts | Sector Perform |
| Mar-06-26 | Downgrade | Barclays | Equal Weight → Underweight |
| Jan-05-26 | Downgrade | Evercore ISI | Outperform → In-line |
| Dec-17-25 | Downgrade | Jefferies | Hold → Underperform |
| Dec-15-25 | Downgrade | BofA Securities | Buy → Neutral |
| Nov-04-25 | Downgrade | Raymond James | Outperform → Mkt Perform |
| Oct-30-25 | Downgrade | Barclays | Overweight → Equal Weight |
| Oct-30-25 | Downgrade | JP Morgan | Overweight → Neutral |
| Aug-01-25 | Downgrade | Jefferies | Buy → Hold |
| Apr-29-25 | Downgrade | Goldman | Buy → Neutral |
| Apr-28-25 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| Apr-28-25 | Downgrade | Stifel | Buy → Hold |
| Apr-28-25 | Downgrade | TD Cowen | Buy → Hold |
| Jan-17-25 | Downgrade | UBS | Buy → Neutral |
| Aug-28-24 | Initiated | Wells Fargo | Overweight |
| Jul-10-24 | Downgrade | Citigroup | Buy → Neutral |
| Jan-04-24 | Upgrade | Evercore ISI | In-line → Outperform |
| Dec-11-23 | Upgrade | TD Cowen | Market Perform → Outperform |
| Sep-28-23 | Initiated | Bernstein | Mkt Perform |
| Jul-31-23 | Downgrade | Evercore ISI | Outperform → In-line |
| Jul-31-23 | Downgrade | William Blair | Outperform → Mkt Perform |
| Jun-21-23 | Initiated | RBC Capital Mkts | Outperform |
| Dec-14-22 | Initiated | Deutsche Bank | Hold |
| Oct-05-22 | Upgrade | Citigroup | Neutral → Buy |
| Sep-14-22 | Downgrade | Cowen | Outperform → Market Perform |
| Sep-09-22 | Downgrade | Cleveland Research | Buy → Neutral |
| Aug-25-22 | Initiated | Credit Suisse | Neutral |
| Apr-04-22 | Downgrade | Citigroup | Buy → Neutral |
| Oct-15-21 | Resumed | Cowen | Outperform |
| Aug-30-21 | Resumed | Raymond James | Outperform |
| Aug-05-21 | Resumed | Credit Suisse | Outperform |
| Aug-02-21 | Upgrade | Piper Sandler | Neutral → Overweight |
| Jun-04-21 | Initiated | Goldman | Buy |
| Apr-29-21 | Upgrade | Stifel | Hold → Buy |
| Mar-03-21 | Initiated | Barclays | Overweight |
| Nov-10-20 | Initiated | KeyBanc Capital Markets | Overweight |
| Sep-14-20 | Initiated | Morgan Stanley | Overweight |
| Jul-15-20 | Upgrade | Cleveland Research | Neutral → Buy |
| Jan-08-20 | Initiated | Wells Fargo | Overweight |
| Jan-07-20 | Initiated | Citigroup | Buy |
| Nov-15-19 | Initiated | Stifel | Hold |
| Aug-02-19 | Initiated | Cleveland Research | Neutral |
| Jun-14-19 | Initiated | Janney | Buy |
| Jun-12-19 | Initiated | Raymond James | Outperform |
| Jun-11-19 | Initiated | Goldman | Buy |
| Jun-11-19 | Initiated | Guggenheim | Buy |
| Jun-11-19 | Initiated | JP Morgan | Overweight |
| Jun-11-19 | Initiated | Jefferies | Buy |
| Jun-11-19 | Initiated | KeyBanc Capital Markets | Sector Weight |
| Jun-11-19 | Initiated | Piper Jaffray | Neutral |
| Jun-11-19 | Initiated | RBC Capital Mkts | Outperform |
| Jun-11-19 | Initiated | Robert W. Baird | Outperform |
| Jun-11-19 | Initiated | SunTrust | Buy |
| Jun-11-19 | Initiated | UBS | Buy |
| Jun-11-19 | Initiated | William Blair | Outperform |
View All
Avantor Inc Stock (AVTR) Latest News
Barclays raises target for Avantor stock from USD 13.00 to USD 15.00 - AD HOC NEWS
Progyny (PGNY) Soars 6.3%: Is Further Upside Left in the Stock? - Zacks Investment Research
Avantor, Inc. (AVTR) Stock Forecasts - Yahoo Finance
Avantor, Inc. (AVTR) Stock Forecasts - Yahoo! Finance Canada
Avantor Inc stock hits 52-week high at 16.05 USD - Investing.com
Avantor Inc stock hits 52-week high at 16.05 USD By Investing.com - Investing.com Nigeria
VTRS vs. AVTR: Which Stock Is the Better Value Option? - Zacks Investment Research
Avantor Inc stock hits 52-week high at 16.05 USD By Investing.com - Investing.com Canada
Avantor Inc (AVTR) Shares Surge 3.1% -- What GF Score of 71 Tells Investors - GuruFocus
Wall Street Zen downgrades Avantor to Hold. Avantor stock gains 1.98 percent - AD HOC NEWS
Global Methyl Grignard Reagent MarketStrategic Forecast, 2026-2032 | Pharmaceutical Demand, AI Process Control, and Resilient Supply Chains Unlock Growth Opportunities - GlobeNewswire Inc.
Avantor Stock Price Forecast. Should You Buy AVTR? - StockInvest.us
Q2 Earnings Review: Research Tools & Consumables Stocks Led by Avantor (NYSE:AVTR) - Yahoo Finance
Avantor, Inc. (AVTR) Stock Forecasts - Yahoo Finance
AVANTOR® TO REPORT THIRD QUARTER 2026 EARNINGS ON WEDNESDAY, OCTOBER 28, 2026 - Moomoo
Avantor® to Report Third Quarter 2026 Earnings on Wednesday, October 28, 2026 - Morningstar
Avantor® to Report Third Quarter 2026 Earnings on Wednesday, October 28, 2026 - tradingview.com
Avantor® to Report Third Quarter 2026 Earnings on Wednesday, October 28, 2026 - Yahoo Finance
Avantor, Inc. (AVTR) Stock Forecasts - Yahoo! Finance Canada
Avantor (NYSE:AVTR)Stock Analysis - Simply Wall Street
Avantor Taps Todd Garner as CFO After Three-Month Interim - MyChesCo
Avantor, Inc. (AVTR) Stock forecasts - Yahoo Finance UK
Avantor, Inc. (AVTR) Stock Forecasts - Yahoo! Finance Canada
Top Avantor (AVTR) Competitors 2026 - MarketBeat
A Look at Avantor Inc (AVTR) After 4.2% Gain -- GF Value $16.87 vs Price $15.38 - GuruFocus
Bronstein, Gewirtz & Grossman, LLC Is Investigating Avantor, Inc. (AVTR) And Encourages Shareholders to Connect - ACCESS Newswire
Avantor, Inc. (AVTR) Stock Forecasts - Yahoo Finance
At $16.61 a share, Avantor (AVTR) grants its CFO options that begin vesting in 2027. - Stock Titan
[Form 3] Avantor, Inc. Initial Statement of Beneficial Ownership - Stock Titan
How Avantor’s New CFO Appointment At Avantor (AVTR) Has Changed Its Investment Story - Yahoo Finance
Are Medical Stocks Lagging Avantor (AVTR) This Year? - Yahoo Finance
Avantor (AVTR) hires new CFO with seven-figure stock grants - Stock Titan
AVTR 8-K FilingsAvantor, Inc. SEC 8-K - Stock Titan
Avantor Names Todd Garner as CFO - Yahoo Finance
Avantor appoints new Chief Financial Officer - PR Newswire
Avantor Broadens RIM Single-Use Bioprocessing Reach in APAC - Yahoo Finance
Here's Why You Should Add Avantor Stock to Your Portfolio for Now - Yahoo Finance
Avantor Stock Has Strong Technical Momentum, But Make Sure Your Stop Losses Are Tight - Yahoo Finance
ETFs Investing in Avantor, Inc. Stocks - tradingview.com
Bronstein, Gewirtz & Grossman, LLC Encourages Avantor, Inc. (AVTR) Stockholders to Inquire about Securities Investigation - ACCESS Newswire
(AVTR) and the Role of Price-Sensitive Allocations - Stock Traders Daily
Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Avantor, Inc. (AVTR) and Encourages Investors to Learn More About the Investigation - ACCESS Newswire
Avantor, Inc. (AVTR) Stock Analysis: Navigating the Healthcare Landscape with a Forward P/E of 16.98 - DirectorsTalk Interviews
Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Avantor, Inc. (AVTR) And Encourages Investors to Reach Out - ACCESS Newswire
2026-09-06 | Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Avantor, Inc. (AVTR) And Encourages Investors to Reach Out | NYSE:AVTR | Press Release - Stockhouse
Is Avantor (AVTR) Stock Outpacing Its Medical Peers This Year? - Yahoo Finance
Avantor stock gains as investors focus on recent earnings and valuation - AD HOC NEWS
Avantor Q2 Earnings Beat Estimates on VWR Growth, Guidance Raised - Eastern Progress
Is It Too Late to Buy Avantor Inc (AVTR) After 3.2% Rally? GF Va - GuruFocus
Bronstein, Gewirtz & Grossman, LLC Is Investigating Avantor, Inc. (AVTR) And Encourages Stockholders to Connect - ACCESS Newswire
Avantor Inc Stock (AVTR) Financials Data
Revenue
Net Income
Cash Flow
EPS
Avantor Inc Stock (AVTR) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| Dingemans Simon | Director |
May 01 '26 |
Buy |
8.14 |
25,000 |
203,500 |
25,000 |
| MEHRA SANJEEV K | Director |
Mar 10 '26 |
Buy |
8.01 |
125,000 |
1,001,250 |
475,000 |
| LUCIER GREGORY T | Director |
Feb 19 '26 |
Buy |
9.16 |
50,000 |
458,000 |
50,000 |
| SUMME GREGORY L | Director |
Feb 12 '26 |
Buy |
9.40 |
100,000 |
940,000 |
400,000 |
| MEHRA SANJEEV K | Director |
Dec 05 '25 |
Buy |
11.09 |
350,000 |
3,881,500 |
350,000 |
| Ligner Emmanuel | President and CEO |
Nov 17 '25 |
Buy |
11.35 |
87,500 |
993,125 |
283,424 |
| Todd Edwards | officer |
Nov 06 '25 |
Proposed Sale |
25.16 |
29,131 |
732,926 |
0 |
| SUMME GREGORY L | Director |
Oct 30 '25 |
Buy |
11.25 |
100,000 |
1,125,000 |
300,000 |
0.13%
1.17%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):